Tag: anti-rejection medications


Novartis taps Alnylam for ambitious push to fix liver function

January 6, 2022

Via: FierceBiotech

Novartis is getting back into bed with Alnylam. More than a decade after severing its ties to the RNAi pioneer, Novartis has returned to the deal table for an ambitious early-stage collaboration to restore liver function in patients with end-stage […]